Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Colgate-Palmolive ( (CL) ) is now available.
On November 3, 2025, Colgate-Palmolive Company entered into an underwriting agreement with Barclays Bank PLC and Banco Bilbao Vizcaya Argentaria, S.A. for the issuance and sale of €600 million in 3.250% Senior Notes due 2035. The issuance, filed under the company’s automatic shelf registration with the SEC, was completed on November 10, 2025, under an existing indenture agreement with The Bank of New York Mellon as trustee, potentially impacting the company’s financial strategy and market positioning.
The most recent analyst rating on (CL) stock is a Hold with a $80.00 price target. To see the full list of analyst forecasts on Colgate-Palmolive stock, see the CL Stock Forecast page.
Spark’s Take on CL Stock
According to Spark, TipRanks’ AI Analyst, CL is a Neutral.
Colgate-Palmolive’s overall score reflects strong financial performance and strategic initiatives, but is tempered by high leverage, operational inefficiencies, and technical weakness. The company’s focus on innovation and emerging markets is positive, but challenges in developed regions and valuation concerns weigh on the outlook.
To see Spark’s full report on CL stock, click here.
More about Colgate-Palmolive
Colgate-Palmolive Company operates in the consumer goods industry, focusing on the production and distribution of household, health care, and personal care products. The company is known for its oral hygiene products, soaps, and cleaning agents, serving a global market.
Average Trading Volume: 5,996,450
Technical Sentiment Signal: Sell
Current Market Cap: $63.49B
Learn more about CL stock on TipRanks’ Stock Analysis page.